Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44977
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCUPPENS, Kristof-
dc.contributor.authorBaas, P.-
dc.contributor.authorWiesweg, M.-
dc.contributor.authorDu Pont, B.-
dc.contributor.authorPloenes, T.-
dc.contributor.authorTheegarten, D.-
dc.contributor.authorAigner, C.-
dc.contributor.authorHartemink, K.-
dc.contributor.authorMAES, Brigitte-
dc.contributor.authorPat, K.-
dc.contributor.authorSchuler, M.-
dc.date.accessioned2025-01-07T09:40:51Z-
dc.date.available2025-01-07T09:40:51Z-
dc.date.issued2024-
dc.date.submitted2025-01-03T11:41:00Z-
dc.identifier.citationJournal of thoracic oncology, 19 (10) , p. S9-
dc.identifier.urihttp://hdl.handle.net/1942/44977-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.subject.otherneoadjuvant-
dc.subject.otherLAG-3-
dc.subject.otherrelatlimab-
dc.titleNeoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up-
dc.typeJournal Contribution-
dc.identifier.issue10-
dc.identifier.spageS9-
dc.identifier.volume19-
local.format.pages1-
local.bibliographicCitation.jcatM-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169 USA-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi001337925600014-
local.provider.typewosris-
local.description.affiliation[Cuppens, K.; Du Pont, B.; Maes, B.; Pat, K.] Jessa Hosp, Hasselt, Belgium.-
local.description.affiliation[Baas, P.; Hartemink, K.] Netherlands Canc Inst, Amsterdam, Netherlands.-
local.description.affiliation[Wiesweg, M.; Theegarten, D.; Schuler, M.] Univ Hosp Essen, Essen, Germany.-
local.description.affiliation[Ploenes, T.] Univ Med Essen, Ruhrlandklin, Essen, Germany.-
local.description.affiliation[Aigner, C.] Med Univ Vienna, Vienna, Austria.-
local.uhasselt.internationalyes-
item.fulltextNo Fulltext-
item.contributorCUPPENS, Kristof-
item.contributorBaas, P.-
item.contributorWiesweg, M.-
item.contributorDu Pont, B.-
item.contributorPloenes, T.-
item.contributorTheegarten, D.-
item.contributorAigner, C.-
item.contributorHartemink, K.-
item.contributorMAES, Brigitte-
item.contributorPat, K.-
item.contributorSchuler, M.-
item.fullcitationCUPPENS, Kristof; Baas, P.; Wiesweg, M.; Du Pont, B.; Ploenes, T.; Theegarten, D.; Aigner, C.; Hartemink, K.; MAES, Brigitte; Pat, K. & Schuler, M. (2024) Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up. In: Journal of thoracic oncology, 19 (10) , p. S9.-
item.accessRightsClosed Access-
crisitem.journal.issn1556-0864-
crisitem.journal.eissn1556-1380-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.